Hubei Cancer Hospital ( Site 4059)

Wuhan, Hubei 430079

0 studies enrolling now · 1 studies all time

What they study most

Endometrial Neoplasms

Studies at this site

• Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053) — Running, not enrolling